Literature DB >> 29203434

Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria.

Eustachio Nettis1, Elisabetta Di Leo2, Caterina Foti3, Luca Cegolon4, Angelo Vacca1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29203434     DOI： 10.1016/j.jaad.2017.11.047

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  1 in total

Review 1.  Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.

Authors:  Désirée E S Larenas-Linnemann; Claudio A S Parisi; Carla Ritchie; Ricardo Cardona-Villa; Ivan Cherrez-Ojeda; Annia Cherrez; Luis Felipe Ensina; Elizabeth Garcia; Iris V Medina; Mónica Rodríguez-González; Jorge Mario Sánchez Caraballo
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-09       Impact factor: 4.806
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.